Share our Story
Learn about our Company
ABOUT Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in todays business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knights list of Global 100 Most Sustainable Corporations. For more information, visit novonordisk.com/sustainability.
Copenhagen Catalogue: Sharing Good Practices in Diabetes Care
(3BL Media) September 3, 2012 - Today the Copenhagen Catalogue, a collection of concrete examples of good practices in diabetes care, is being launched. The catalogue originates from the European Diabetes Leadership Forum which took place in Copenhagen on 25-26 April 2012 emphasising that sharing information about the many existing successful practices is crucial in times of financial crisis.